
Company Number
03798902
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Research and experimental development on social sciences and humanities
Registered Address
the foundry 17 oval way, london, SE11 5RR
Website
https://www.ilcuk.org.ukPomanda estimates the enterprise value of INTERNATIONAL LONGEVITY CENTRE - UK at £774.8k based on a Turnover of £922.6k and 0.84x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INTERNATIONAL LONGEVITY CENTRE - UK at £0 based on an EBITDA of £-352.7k and a 4.75x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INTERNATIONAL LONGEVITY CENTRE - UK at £1.2m based on Net Assets of £349.6k and 3.5x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
International Longevity Centre - Uk is a live company located in london, SE11 5RR with a Companies House number of 03798902. It operates in the research and experimental development on social sciences and humanities sector, SIC Code 72200. Founded in June 1999, it's largest shareholder is unknown. International Longevity Centre - Uk is a mature, small sized company, Pomanda has estimated its turnover at £922.6k with healthy growth in recent years.
Pomanda's financial health check has awarded International Longevity Centre - Uk a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
4 Weak
Size
annual sales of £922.6k, make it in line with the average company (£825.5k)
£922.6k - International Longevity Centre - Uk
£825.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a slower rate (8.8%)
6% - International Longevity Centre - Uk
8.8% - Industry AVG
Production
with a gross margin of 42.1%, this company has a comparable cost of product (42.1%)
42.1% - International Longevity Centre - Uk
42.1% - Industry AVG
Profitability
an operating margin of -38.2% make it less profitable than the average company (5.1%)
-38.2% - International Longevity Centre - Uk
5.1% - Industry AVG
Employees
with 15 employees, this is similar to the industry average (14)
15 - International Longevity Centre - Uk
14 - Industry AVG
Pay Structure
on an average salary of £47.9k, the company has an equivalent pay structure (£47.1k)
£47.9k - International Longevity Centre - Uk
£47.1k - Industry AVG
Efficiency
resulting in sales per employee of £61.5k, this is less efficient (£89.9k)
£61.5k - International Longevity Centre - Uk
£89.9k - Industry AVG
Debtor Days
it gets paid by customers after 15 days, this is earlier than average (30 days)
15 days - International Longevity Centre - Uk
30 days - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is quicker than average (13 days)
5 days - International Longevity Centre - Uk
13 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - International Longevity Centre - Uk
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 141 weeks, this is more cash available to meet short term requirements (79 weeks)
141 weeks - International Longevity Centre - Uk
79 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 27.7%, this is a lower level of debt than the average (35.7%)
27.7% - International Longevity Centre - Uk
35.7% - Industry AVG
International Longevity Centre - Uk's latest turnover from March 2024 is £922.6 thousand and the company has net assets of £349.6 thousand. According to their latest financial statements, International Longevity Centre - Uk has 15 employees and maintains cash reserves of £364.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 922,641 | 1,275,129 | 847,517 | 781,815 | 761,843 | 757,651 | 719,183 | 568,802 | 695,294 | 635,592 | 756,955 | 472,884 | 538,699 | 562,192 | 397,547 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | -329,141 | 269,604 | -141,850 | 88,320 | -95,280 | -66,923 | 10,467 | -38,654 | 93,961 | 88,199 | -15,827 | -108,593 | -37,008 | 77,404 | 158,054 |
Tax | |||||||||||||||
Profit After Tax | -329,141 | 269,604 | -141,850 | 88,320 | -95,280 | -66,923 | 10,467 | -38,654 | 93,961 | 88,199 | -15,827 | -108,593 | -37,008 | 77,404 | 158,054 |
Dividends Paid | |||||||||||||||
Retained Profit | -329,141 | 269,604 | -141,850 | 88,320 | -95,280 | -66,923 | 10,467 | -38,654 | 93,961 | 88,199 | -15,827 | -108,593 | -37,008 | 77,404 | 158,054 |
Employee Costs | 718,240 | 636,826 | 612,510 | 588,523 | 567,219 | 636,731 | 595,938 | 549,890 | 501,306 | 463,354 | 532,649 | 456,729 | 442,163 | 346,792 | 213,261 |
Number Of Employees | 15 | 14 | 13 | 12 | 13 | 13 | 13 | 13 | 12 | 11 | 10 | 10 | 11 | 9 | 6 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 836 | 1,815 | 6,910 | 9,287 | 15,174 | 5,752 | 6,146 | 2,844 | 1,940 | 3,602 | 3,418 | 3,170 | 3,273 | ||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 836 | 1,815 | 6,910 | 9,287 | 15,174 | 5,752 | 6,146 | 2,844 | 1,940 | 3,602 | 3,418 | 3,170 | 3,273 | ||
Stock & work in progress | |||||||||||||||
Trade Debtors | 39,763 | 81,165 | 279,828 | 89,967 | 53,152 | 96,888 | 86,870 | 50,828 | 48,185 | 44,986 | 232,697 | 193,045 | 125,750 | 84,881 | 132,148 |
Group Debtors | |||||||||||||||
Misc Debtors | 78,884 | 216,563 | 16,069 | 131,717 | 192,752 | 67,333 | 80,860 | 70,410 | 134,166 | 19,941 | 8,340 | 3,830 | |||
Cash | 364,763 | 531,514 | 337,923 | 725,683 | 359,189 | 418,931 | 643,956 | 604,861 | 548,434 | 389,499 | 248,405 | 312,224 | 470,399 | 552,067 | 422,561 |
misc current assets | |||||||||||||||
total current assets | 483,410 | 829,242 | 633,820 | 815,650 | 544,058 | 708,571 | 798,159 | 736,549 | 667,029 | 568,651 | 481,102 | 505,269 | 616,090 | 645,288 | 558,539 |
total assets | 483,410 | 829,242 | 634,656 | 817,465 | 550,968 | 717,858 | 813,333 | 742,301 | 673,175 | 571,495 | 483,042 | 508,871 | 619,508 | 648,458 | 561,812 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 8,502 | 27,080 | 16,243 | 19,292 | 31,513 | 65,631 | 70,223 | 62,452 | 3,155 | 1,441 | 3,128 | 12,267 | 13,827 | 7,493 | 2,051 |
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 125,330 | 123,443 | 209,282 | 247,192 | 56,794 | 94,286 | 118,246 | 65,452 | 16,969 | 10,964 | 9,023 | 9,886 | 10,370 | 8,646 | 4,846 |
total current liabilities | 133,832 | 150,523 | 225,525 | 266,484 | 88,307 | 159,917 | 188,469 | 127,904 | 20,124 | 12,405 | 12,151 | 22,153 | 24,197 | 16,139 | 6,897 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | |||||||||||||||
total liabilities | 133,832 | 150,523 | 225,525 | 266,484 | 88,307 | 159,917 | 188,469 | 127,904 | 20,124 | 12,405 | 12,151 | 22,153 | 24,197 | 16,139 | 6,897 |
net assets | 349,578 | 678,719 | 409,131 | 550,981 | 462,661 | 557,941 | 624,864 | 614,397 | 653,051 | 559,090 | 470,891 | 486,718 | 595,311 | 632,319 | 554,915 |
total shareholders funds | 349,578 | 678,719 | 409,131 | 550,981 | 462,661 | 557,941 | 624,864 | 614,397 | 653,051 | 559,090 | 470,891 | 486,718 | 595,311 | 632,319 | 554,915 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 979 | 5,095 | 5,727 | 6,451 | 7,040 | 2,924 | 2,948 | 2,012 | 1,662 | 2,447 | 2,248 | 1,623 | 1,976 | ||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | -179,081 | 1,831 | 205,930 | -94,902 | -104,771 | 135,437 | 22,515 | 13,093 | -60,557 | -53,545 | 39,652 | 47,354 | 52,470 | -42,757 | 135,978 |
Creditors | -18,578 | 10,837 | -3,049 | -12,221 | -34,118 | -4,592 | 7,771 | 59,297 | 1,714 | -1,687 | -9,139 | -1,560 | 6,334 | 5,442 | 2,051 |
Accruals and Deferred Income | 1,887 | -85,839 | -37,910 | 190,398 | -37,492 | -23,960 | 52,794 | 48,483 | 6,005 | 1,941 | -863 | -484 | 1,724 | 3,800 | 4,846 |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | -16,462 | -1,918 | |||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | -16,462 | -1,918 | |||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | -16 | 396,861 | |||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -166,751 | 193,591 | -387,760 | 366,494 | -59,742 | -225,025 | 39,095 | 56,427 | 158,935 | 141,094 | -63,819 | -158,175 | -81,668 | 129,506 | 422,561 |
overdraft | |||||||||||||||
change in cash | -166,751 | 193,591 | -387,760 | 366,494 | -59,742 | -225,025 | 39,095 | 56,427 | 158,935 | 141,094 | -63,819 | -158,175 | -81,668 | 129,506 | 422,561 |
Perform a competitor analysis for international longevity centre - uk by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in SE11 area or any other competitors across 12 key performance metrics.
INTERNATIONAL LONGEVITY CENTRE - UK group structure
International Longevity Centre - Uk has 1 subsidiary company.
Ultimate parent company
INTERNATIONAL LONGEVITY CENTRE - UK
03798902
1 subsidiary
International Longevity Centre - Uk currently has 14 directors. The longest serving directors include Mr Glyn Ryland (Mar 2013) and Ms Annabel Scarfe Mbe (Sep 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Glyn Ryland | 62 years | Mar 2013 | - | Director | |
Ms Annabel Scarfe Mbe | England | 70 years | Sep 2019 | - | Director |
Mr Sanjeev Chhugani | England | 56 years | Mar 2023 | - | Director |
Mr Paul Green | England | 60 years | Jul 2023 | - | Director |
Ms Susan Lewis | England | 71 years | Jul 2023 | - | Director |
Ms Helene Panzarino | England | 64 years | Jul 2023 | - | Director |
Ms Janet Sutherland | United Kingdom | 74 years | Jul 2023 | - | Director |
Dr Pol Vandenbroucke | England | 66 years | Jul 2023 | - | Director |
Mr Alexander Evans | 51 years | Jul 2023 | - | Director | |
Mrs Jean Jackson | England | 68 years | Jul 2023 | - | Director |
P&L
March 2024turnover
922.6k
-28%
operating profit
-352.7k
0%
gross margin
42.2%
-38.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
349.6k
-0.48%
total assets
483.4k
-0.42%
cash
364.8k
-0.31%
net assets
Total assets minus all liabilities
company number
03798902
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
72200 - Research and experimental development on social sciences and humanities
incorporation date
June 1999
age
26
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
NYMAN LIBSON PAUL LLP
address
the foundry 17 oval way, london, SE11 5RR
Bank
C A F BANK LTD
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to international longevity centre - uk.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INTERNATIONAL LONGEVITY CENTRE - UK. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|